On February 18, 2026, Teladoc Health, Inc. appointed Michael S. Smith as a director, increasing the board size to ten members, following the upcoming resignation of Thomas G. McKinley on February 20, 2026. This filing is considered significant and has a neutral sentiment from an equity investor perspective.